Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

233 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A small circulating miRNAs signature predicts mortality and adverse cardiovascular outcomes in chronic hemodialysis patients.
Bolignano D, Greco M, Presta P, Duni A, Vita C, Pappas E, Mirabelli M, Lakkas L, Naka KK, Brunetti A, Foti DP, Andreucci M, Coppolino G, Dounousi E. Bolignano D, et al. Among authors: vita c. Clin Kidney J. 2023 Jan 25;16(5):868-878. doi: 10.1093/ckj/sfad017. eCollection 2023 May. Clin Kidney J. 2023. PMID: 37151423 Free PMC article.
Cathepsin-K is a potential cardiovascular risk biomarker in prevalent hemodialysis patients.
Bolignano D, Greco M, Arcidiacono V, Tripolino O, Vita C, Provenzano M, Donato C, Chiarella S, Fuiano G, De Sarro G, Russo E, Andreucci M, Foti DP, Coppolino G. Bolignano D, et al. Among authors: vita c. Int Urol Nephrol. 2021 Jan;53(1):171-175. doi: 10.1007/s11255-020-02602-y. Epub 2020 Aug 13. Int Urol Nephrol. 2021. PMID: 32794117
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial.
Rovin BH, Barratt J, Heerspink HJL, Alpers CE, Bieler S, Chae DW, Diva UA, Floege J, Gesualdo L, Inrig JK, Kohan DE, Komers R, Kooienga LA, Lafayette R, Maes B, Małecki R, Mercer A, Noronha IL, Oh SW, Peh CA, Praga M, Preciado P, Radhakrishnan J, Rheault MN, Rote WE, Tang SCW, Tesar V, Trachtman H, Trimarchi H, Tumlin JA, Wong MG, Perkovic V; DUPRO steering committee and PROTECT Investigators. Rovin BH, et al. Lancet. 2023 Dec 2;402(10417):2077-2090. doi: 10.1016/S0140-6736(23)02302-4. Epub 2023 Nov 3. Lancet. 2023. PMID: 37931634 Clinical Trial.
Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial.
Heerspink HJL, Radhakrishnan J, Alpers CE, Barratt J, Bieler S, Diva U, Inrig J, Komers R, Mercer A, Noronha IL, Rheault MN, Rote W, Rovin B, Trachtman H, Trimarchi H, Wong MG, Perkovic V; PROTECT Investigators. Heerspink HJL, et al. Lancet. 2023 May 13;401(10388):1584-1594. doi: 10.1016/S0140-6736(23)00569-X. Epub 2023 Apr 1. Lancet. 2023. PMID: 37015244 Clinical Trial.
Applying the Participatory Slow Design Approach to a mHealth Application for Family Caregivers in Pediatric Ear, Nose, and Throat Surgery.
Dobrina R, Starec A, Brunelli L, Orzan E, De Vita C, Bicego L, Ronfani L, Castro V, Di Rocco P, Zanchiello S, Dal Cin M, Tagliapietra B, Cinello M, Fontanot D, Stampalija T, Dante A, Petrucci C, Cassone A. Dobrina R, et al. Among authors: de vita c. Healthcare (Basel). 2024 Feb 8;12(4):442. doi: 10.3390/healthcare12040442. Healthcare (Basel). 2024. PMID: 38391818 Free PMC article.
High-Dose Inhaled Nitric Oxide in Acute Hypoxemic Respiratory Failure Due to COVID-19: A Multicenter Phase II Trial.
Di Fenza R, Shetty NS, Gianni S, Parcha V, Giammatteo V, Safaee Fakhr B, Tornberg D, Wall O, Harbut P, Lai PS, Li JZ, Paganoni S, Cenci S, Mueller AL, Houle TT, Akeju O, Bittner EA, Bose S, Scott LK, Carroll RW, Ichinose F, Hedenstierna M, Arora P, Berra L; Nitric Oxide Investigators. Di Fenza R, et al. Am J Respir Crit Care Med. 2023 Dec 15;208(12):1293-1304. doi: 10.1164/rccm.202304-0637OC. Am J Respir Crit Care Med. 2023. PMID: 37774011 Free PMC article. Clinical Trial.
233 results